Total operating profit (loss)
McKesson·Business Segments·3 segments
Breakdown
| Segment | FY'21 | FY'22 | FY'23 | FY'24 | FY'25 |
|---|---|---|---|---|---|
| U.S. Pharmaceutical | $2.76B | $2.88B | $3.21B | $2.79B | $4.00B |
| Medical-Surgical Solutions | $707.00M | $959.00M | $1.12B | $952.00M | $773.00M |
| International | -$37.00M | -$968.00M | $136.00M | $319.00M | -$213.00M |
| Total | $707.00M | $959.00M | $1.12B | $952.00M | $773.00M |
All segment values are derived from annual filings.